Hisamitsu Pharmaceutical Management
Management criteria checks 1/4
Hisamitsu Pharmaceutical's CEO is Kazue Nakatomi, appointed in May 2015, has a tenure of 9.5 years. directly owns 0.33% of the company’s shares, worth ¥1.05B. The average tenure of the management team and the board of directors is 1.3 years and 10.5 years respectively.
Key information
Kazue Nakatomi
Chief executive officer
n/a
Total compensation
CEO salary percentage | n/a |
CEO tenure | 9.5yrs |
CEO ownership | 0.3% |
Management average tenure | 1.3yrs |
Board average tenure | 10.5yrs |
Recent management updates
Recent updates
Hisamitsu Pharmaceutical (TSE:4530) Has Announced A Dividend Of ¥45.00
Nov 08We Think Hisamitsu Pharmaceutical (TSE:4530) Can Stay On Top Of Its Debt
Nov 04Hisamitsu Pharmaceutical's (TSE:4530) Solid Earnings May Rest On Weak Foundations
Oct 17Hisamitsu Pharmaceutical Co., Inc. (TSE:4530) Not Lagging Market On Growth Or Pricing
Sep 16Hisamitsu Pharmaceutical's (TSE:4530) Shareholders Will Receive A Bigger Dividend Than Last Year
Aug 20Hisamitsu Pharmaceutical (TSE:4530) Has Announced That It Will Be Increasing Its Dividend To ¥45.00
Jul 26Hisamitsu Pharmaceutical (TSE:4530) Is Paying Out A Larger Dividend Than Last Year
Jul 11Hisamitsu Pharmaceutical's (TSE:4530) Dividend Will Be Increased To ¥45.00
Jun 27Hisamitsu Pharmaceutical (TSE:4530) Is Increasing Its Dividend To ¥45.00
Jun 13Why We're Not Concerned About Hisamitsu Pharmaceutical Co., Inc.'s (TSE:4530) Share Price
Apr 09Here's Why We Think Hisamitsu Pharmaceutical (TSE:4530) Is Well Worth Watching
Mar 18CEO
Kazue Nakatomi (52 yo)
9.5yrs
Tenure
Mr. Kazuhide Nakatomi, also known as Kazue, serves as Chief Executive Officer since May 2019, President since May 2015 & Director since May 2007 at Hisamitsu Pharmaceutical Co. Inc. and served as its Chief...
Leadership Team
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 9.5yrs | no data | 0.33% ¥ 1.0b | |
Executive VP | less than a year | no data | no data | |
Exe Officer of Legal Affairs | 10.5yrs | no data | 0.0068% ¥ 21.4m | |
Executive MD of Human Resources | less than a year | no data | 0.018% ¥ 55.6m | |
Senior Managing Executive Officer | less than a year | no data | no data | |
MD, Executive Officer | no data | no data | 0.0095% ¥ 29.9m | |
Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director | no data | no data | 0.0082% ¥ 25.7m | |
Senior Executive Officer & GM of Pharmaceutical Business Division | no data | no data | no data | |
Senior Executive Officer and GM of the Pharmaceuticals & Cosmetics Division | no data | no data | no data | |
Executive Officer | 3.5yrs | no data | 0.0041% ¥ 12.8m | |
Senior Executive Officer & GM of MN Business Promotion Office | 1.8yrs | no data | no data | |
Executive Officer and GM of the Regional Mass Sales Dept of Pharmaceuticals & Cosmetics Division | less than a year | no data | no data |
1.3yrs
Average Tenure
58.5yo
Average Age
Experienced Management: 4530's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
President | 17.5yrs | no data | 0.33% ¥ 1.0b | |
Exe Officer of Legal Affairs | 10.5yrs | no data | 0.0068% ¥ 21.4m | |
Executive MD of Human Resources | 25.5yrs | no data | 0.018% ¥ 55.6m | |
MD, Executive Officer | 11.5yrs | no data | 0.0095% ¥ 29.9m | |
Executive Officer of Mgmt. of Internal Audit Division & Domestic Subsidiary Division and Director | 10.5yrs | no data | 0.0082% ¥ 25.7m | |
Executive Officer | 3.5yrs | no data | 0.0041% ¥ 12.8m | |
Standing Corporate Auditor | 18.5yrs | no data | 0.0027% ¥ 8.6m | |
Part-time Outside Independent Director | 4.5yrs | no data | 0.0014% ¥ 4.3m | |
Part-time Outside Independent Director | 4.5yrs | no data | no data | |
Part Time Outside Corporate Auditor | 1.5yrs | no data | no data | |
Part Time Outside Independent Director | 1.5yrs | no data | no data |
10.5yrs
Average Tenure
57yo
Average Age
Experienced Board: 4530's board of directors are seasoned and experienced ( 10.5 years average tenure).